NORADA BIOSYSTEMS: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
NORADA BIOSYSTEMS
Largest movements
- Cash -€32,788
down €32,788 (-70.9%), from €46,277 to €13,489
mainly Contributions, distributions and other (-€35,000) and Net result for the year (-€2,865)
- Receivables within one year -€1,170
down €1,170 (-45.8%), from €2,554 to €1,384
- Profit (loss) carried forward -€37,865
down €37,865 (-84.8%), from €44,642 to €6,776
- Other debts +€2,667
up €2,667 (+1413.5%), from €189 to €2,855
- Trade debts +€1,241
new in 2025: €1,241
- Gross operating margin -€42,142
down €42,142, from €39,321 to -€2,820
- Taxes -€9,164
no longer reported in 2025 (was €9,164)
- Financial income -€2,083
no longer reported in 2025 (was €2,083)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €48,830 | €14,873 | -€33,958 | -69.5% |
| Current assets | 29/58 | €48,830 | €14,873 | -€33,958 | -69.5% |
| Amounts receivable within one year | 40/41 | €2,554 | €1,384 | -€1,170 | -45.8% |
| Other amounts receivable | 41 | €2,554 | €1,384 | -€1,170 | -45.8% |
| Cash at bank and in hand | 54/58 | €46,277 | €13,489 | -€32,788 | -70.9% |
| Total equity and liabilities | 10/49 | €48,830 | €14,873 | -€33,958 | -69.5% |
| Equity | 10/15 | €48,642 | €10,776 | -€37,865 | -77.8% |
| Contributions | 10/11 | €4,000 | €4,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €44,642 | €6,776 | -€37,865 | -84.8% |
| Amounts payable | 17/49 | €189 | €4,096 | +€3,908 | +2071.5% |
| Amounts payable within one year | 42/48 | €189 | €4,096 | +€3,908 | +2071.5% |
| Trade debts | 44 | - | €1,241 | +€1,241 | |
| Suppliers | 440/4 | - | €1,241 | +€1,241 | |
| Other amounts payable | 47/48 | €189 | €2,855 | +€2,667 | +1413.5% |
| Non-recurring operating income | 76A | €9,906 | - | -€9,906 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €145 | - | -€145 | |
| Other operating charges | 640/8 | €387 | - | -€387 | |
| Gross operating margin | 9900 | €39,321 | -€2,820 | -€42,142 | |
| Operating profit (loss) | 9901 | €38,789 | -€2,820 | -€41,610 | |
| Financial income | 75/76B | €2,083 | - | -€2,083 | |
| Recurring financial income | 75 | €2,083 | - | -€2,083 | |
| Financial charges | 65/66B | €110 | €45 | -€65 | -59.2% |
| Recurring financial charges | 65 | €110 | €45 | -€65 | -59.2% |
| Profit (loss) for the period before taxes | 9903 | €40,763 | -€2,865 | -€43,628 | |
| Income taxes | 67/77 | €9,164 | - | -€9,164 | |
| Profit (loss) for the period | 9904 | €31,598 | -€2,865 | -€34,464 | |
| Profit (loss) for the period to be appropriated | 9905 | €31,598 | -€2,865 | -€34,464 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.